brain metastatic breast cancer cell line 231-BR; parental nonspecific metastatic cell line MDA-MB-231
231-BR; MDA-MB-231
-
not specified
RT-qPCR; Sanger Sequencing; Back-Splice Junction PCR / divergent primers PCR; RNase R Treatment; RNA-seq; Clinical Sample Validation
may be used as biomarkers for diagnosis and prediction of BCBM; may also be therapeutic targets
hsa circ 0000732 is significantly upregulated in breast cancer brain metastasis cells and was validated by RNA-seq and RT-qPCR. No specific downstream mechanism was established in this study.
0.5909
Circular RNA profile of breast cancer brain metastasis: identification of potential biomarkers and therapeutic targets.
biological research